Feifei Li

Hefei, 230032, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Characterization of the biological and transcriptomic signatures of natural killer cells derived from cord blood and peripheral blood.

Characterization of the biological and transcriptomic signatures of natural killer cells derived from cord blood and peripheral blood.

Journal: American journal of cancer research
Published: June 03, 2023

Decoding the biological properties and transcriptomic landscapes of human natural killer cells derived from bone marrow and umbilical cord blood.

Decoding the biological properties and transcriptomic landscapes of human natural killer cells derived from bone marrow and umbilical cord blood.

Journal: American journal of cancer research
Published: December 21, 2022

Role of RUNX2 in breast cancer development and drug resistance (Review).

Role of RUNX2 in breast cancer development and drug resistance (Review).

Journal: Oncology letters
Published: December 09, 2022

RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1.

RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1.

Journal: Frontiers in oncology
Published: July 17, 2022

Research advances in chimeric antigen receptor-modified T-cell therapy (Review).

Research advances in chimeric antigen receptor-modified T-cell therapy (Review).

Journal: Experimental and therapeutic medicine
Published: August 11, 2020

miR-205/RunX2 axis negatively regulates CD44+/CD24- breast cancer stem cell activity.

miR-205/RunX2 axis negatively regulates CD44+/CD24- breast cancer stem cell activity.

Journal: American journal of cancer research
Published: April 29, 2020

Runx2 is required for activity of CD44+/CD24-/low breast cancer stem cell in breast cancer development.

Runx2 is required for activity of CD44+/CD24-/low breast cancer stem cell in breast cancer development.

Journal: American journal of translational research
Published: March 21, 2020

tRNA-derived fragment tRF-03357 promotes cell proliferation, migration and invasion in high-grade serous ovarian cancer.

tRNA-derived fragment tRF-03357 promotes cell proliferation, migration and invasion in high-grade serous ovarian cancer.

Journal: OncoTargets and therapy
Published: February 26, 2019

TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis.

TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis.

Journal: Biochemical and biophysical research communications
Published: May 13, 2018

Inactivation of miR-100 combined with arsenic treatment enhances the malignant transformation of BEAS-2B cells via stimulating epithelial -mesenchymal transition.

Inactivation of miR-100 combined with arsenic treatment enhances the malignant transformation of BEAS-2B cells via stimulating epithelial -mesenchymal transition.

Journal: Cancer biology & therapy
Published: September 29, 2017

Runx2-interacting genes identified by yeast two-hybrid screening of libraries generated from hypertrophic chondrocytes.

Runx2-interacting genes identified by yeast two-hybrid screening of libraries generated from hypertrophic chondrocytes.

Journal: American journal of translational research
Published: August 04, 2016
Showing 1-11 of 11

Last Updated: 09/26/2026